4-Hydroxybenzophenone

CAS No. 1137-42-4

4-Hydroxybenzophenone( —— )

Catalog No. M10481 CAS No. 1137-42-4

Used in organic synthesis, is an intermediates of infertility drugs Clomifene .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 37 In Stock
10MG 45 In Stock
25MG 61 In Stock
50MG 98 In Stock
100MG 129 In Stock
200MG 181 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-Hydroxybenzophenone
  • Note
    Research use only, not for human use.
  • Brief Description
    Used in organic synthesis, is an intermediates of infertility drugs Clomifene .
  • Description
    Used in organic synthesis, is an intermediates of infertility drugs Clomifene .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1137-42-4
  • Formula Weight
    198.22
  • Molecular Formula
    C13H10O2
  • Purity
    >98% (HPLC)
  • Solubility
    Limited solubility
  • SMILES
    OC1=CC=C(C=C1)C(=O)C1=CC=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Buck Louis GM, et al. Am J Epidemiol. 2014 Dec 15;180(12):1168-75.
molnova catalog
related products
  • Trometamol hydrochlo...

    Trometamol hydrochloride (Tromethamine hydrochloride) is a biologically inert amino alcohol of low toxicity, which buffers carbon dioxide and acids in vitro and in vivo.

  • Fz7-21

    Fz7-21 is a peptide antagonist of FZD7 . It antagonises WNT3A-induced Wnt-β-catenin signalling in HEK293 expressing FZD7. Fz7-21 impairs Wnt/β-catenin signaling in HEK293 cells stimulated with exogenous WNT3A (IC50=100?nM) or transfected with a construct expressing WNT3A or WNT1. Fz7-21 also blocks WNT3A-mediated stabilization of β-catenin in mouse L cells (IC50=50?nM).

  • EGCG Octaacetate

    EGCG Octaacetate a prodrug of EGCG is utilized to enhance the stability and bioavailability of EGCG in vivo. It has high efficacy bioavailability anti-oxidation and anti-angiogenesis capacities.